TBPH
Theravance Biopharma Inc
17.00$
+0.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -70.2% | -45.8% | +13.7% | +21.8% | +5.6% | +84.3% | +182.2% | -45.3% | +22.6% | -66.1% | +389.9% | -52.5% | +137.4% | -32.7% | -24.4% | +21.6% | +2.6% | -23.9% | -9.4% | +2.2% | +13.3% | -11.7% | -16.3% | +12.7% | +17.7% | -28.9% | +32.0% | +14.1% | +11.9% | -17.4% | -1.7% | +18.3% | +11.2% | -17.9% | +70.2% | -23.7% | +129.6% | -61.4% | +17.1% | – | |
| – | +245.2% | -50.7% | +141.4% | -27.8% | +216.3% | -73.5% | +5,611.0% | -98.5% | -10.4% | +8,415.5% | -13.8% | +12.1% | +28.9% | -1.5% | -5.5% | +8.0% | -3.3% | +3.7% | -24.4% | -14.4% | -28.6% | -25.5% | -35.8% | -33.9% | +55.5% | -5.1% | -35.3% | -85.8% | +520.8% | +7.9% | +11.0% | -6.9% | +2.0% | +21.1% | -8.4% | -22.7% | -81.4% | -4.6% | +0.4% | – | |
| – | -75.7% | -44.5% | -14.9% | +53.4% | -57.5% | +435.6% | -416.3% | – | +24.5% | -421.0% | – | – | – | -32.7% | -24.4% | +21.6% | -354.3% | – | – | – | – | – | – | – | -127.1% | – | – | +232.0% | -35.5% | -40.2% | -22.3% | +76.7% | +22.4% | -57.7% | +299.0% | -24.4% | +273.7% | -60.1% | +9.0% | – | |
| – | +31.5% | -3.4% | +5.8% | -8.3% | +29.8% | -6.4% | +1.8% | +8.4% | -0.8% | +3.0% | -13.8% | +12.1% | +28.9% | -1.5% | -5.5% | +8.0% | +3.1% | -0.6% | -24.2% | -10.1% | -29.6% | -25.2% | -33.6% | -30.0% | +50.1% | -5.6% | -30.3% | -30.7% | +14.2% | -0.3% | +11.0% | -6.9% | +1.2% | +22.2% | -8.4% | -22.7% | -14.2% | -16.3% | -19.2% | – | |
| – | +0.4% | +2.1% | +17.1% | -13.9% | +41.0% | -16.3% | +1.2% | -12.5% | +16.3% | -1.1% | -11.7% | +15.3% | +29.0% | -20.3% | -5.9% | +11.0% | +9.3% | +1.6% | -15.1% | -17.9% | +1.0% | -11.1% | -11.2% | -4.2% | -46.4% | +119.7% | +0.5% | -16.3% | -33.4% | +55.8% | +1.9% | -1.1% | -15.8% | +29.4% | +0.3% | -0.5% | +1.0% | -4.3% | -20.0% | – | |
| – | +19.4% | -1.6% | +9.6% | -10.4% | +33.7% | -10.1% | +1.6% | +1.3% | +4.2% | +1.6% | -13.1% | +13.1% | +28.9% | -7.7% | -5.6% | +8.8% | -68.3% | +1.6% | -15.1% | -11.0% | +72.9% | -31.9% | -29.2% | -12.7% | -0.3% | +24.1% | -1.5% | +13.0% | -33.0% | +8.1% | +19.5% | -7.8% | +0.3% | -0.7% | +0.3% | -0.5% | +46.3% | -12.2% | -15.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -133.3% | – | – | |
| – | +170.3% | +129.8% | +0.0% | 0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +90.5% | +93.0% | +0.5% | +2.1% | -0.4% | +23.7% | +14.6% | +1.6% | +0.9% | +3.7% | -4.1% | -81.6% | +446.0% | -81.7% | +0.0% | -27.7% | -64.3% | -0.2% | +3.3% | +7.2% | +2.3% | +1.0% | +2.4% | -2.2% | +2.1% | +0.0% | +3.1% | -13.6% | +1.7% | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -103.9% | – | -108.9% | – | – | |
| – | +955.2% | -37.2% | -91.6% | +91.2% | +705.1% | -97.9% | -4,815.3% | – | – | – | +151.3% | -2,862.2% | – | +200.0% | -73.5% | +138.5% | +9,361.3% | -97.4% | -3.1% | -96.8% | +2,057.4% | +247.0% | -99.0% | +10,042.0% | -99.4% | +13,071.0% | +269.1% | -6.2% | +155.6% | -63.9% | +3.6% | +102.3% | +149.0% | -108.5% | – | -135.4% | – | -112.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -101.1% | – | – | – | – | – | – | – | – | – | – | -93.4% | +1,588.1% | -108.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -102.3% | – | -107.5% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.